BIRAC GCI — Screening & Diagnosis Innovations Open Call — Eligibility Criteria

This program welcomes applications from Indian academic and research institutions, public and private R&D organizations, startups incorporated in India, and not-for-profit foundations. Applicants must focus on developing screening and diagnostic innovations for tuberculosis, emerging pathogens, syndromic panels, or enteric pathogens. Solutions should ideally be ultra-low-cost and suitable for near point-of-care use. Proposals with high-risk, high-reward potential are encouraged, and multidisciplinary collaborations involving academic, clinical, and industry partners are highly valued.

BIRAC GCI — Screening & Diagnosis Innovations Open Call is open to startups at the idea, product and revenue stage working in health pharma biotech. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and partnership.